Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
|
|
Bionano Genomics, Inc. (BNGO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/18/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/18/2022 |
4/A
| Luderer Albert (Director) has filed a Form 4 on Bionano Genomics, Inc.|
Txns:
| Granted 44,470 options to buy
@ $0.51, valued at
$22.7k
|
|
| 07/18/2022 |
4/A
| Linney Yvonne (Director) has filed a Form 4 on Bionano Genomics, Inc.|
Txns:
| Granted 44,470 options to buy
@ $0.51, valued at
$22.7k
|
|
| 07/18/2022 |
4/A
| Vuori Kristiina MD (Director) has filed a Form 4 on Bionano Genomics, Inc.|
Txns:
| Granted 44,470 options to buy
@ $0.51, valued at
$22.7k
|
|
| 07/18/2022 |
4/A
| Mamuszka Hannah (Director) has filed a Form 4 on Bionano Genomics, Inc.|
Txns:
| Granted 44,470 options to buy
@ $0.51, valued at
$22.7k
|
|
| 09/03/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
|
|